Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 67Lung Neoplasms 29Brain Neoplasms 11Head and Neck Neoplasms 10Neoplasms 9Esophageal Neoplasms 9Breast Neoplasms 8Adenocarcinoma of Lung 8Adenocarcinoma Of Esophagus 7Glioblastoma 6Gliosarcoma 5Esophageal Squamous Cell Carcinoma 5NSCLC 4Central Nervous System Neoplasms 4Adenocarcinoma, Bronchiolo-Alveolar 4Squamous Cell Carcinoma of Head and Neck 3Rectal Neoplasms 3Prostatic Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Colorectal Neoplasms 3Colonic Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Stomach Neoplasms 2Osteosarcoma 2Oligodendroglioma 2Neuroblastoma 2Lymphoid Interstitial Pneumonia 2Laryngeal Diseases 2Glioma 2

Interventions

Gemcitabine 406Oxaliplatin 131Fluorouracil 125130-nm albumin-bound paclitaxel 108Capecitabine 100Albumin-Bound Paclitaxel 90Leucovorin 88Irinotecan 87Radiotherapy 76Radiosurgery 64Taxes 63Cisplatin 56Erlotinib Hydrochloride 44Drug Therapy 42folfirinox 40Magnetic Resonance Spectroscopy 39pembrolizumab 35Blood Specimen Collection 33S 1 (combination) 31Pancreaticoduodenectomy 31Docetaxel 31Nivolumab 30Bevacizumab 30Biopsy 26Surgical Procedures, Operative 25Cyclophosphamide 25irinotecan sucrosofate 24Specimen Handling 24Radiation 22Standard of Care 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pancreatic Neoplasms × Gefitinib × Clear all
NCT00137761 2009-11-02

Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer

Dana-Farber Cancer Institute

Phase 2 Completed
32 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡